Mohsen Messaoudi | Genetics | Research Excellence Award

Published on by Global Scholar Awards

Mr. Mohsen Messaoudi | Genetics | Research Excellence Award

Université de Tunis El Manar | Tunisia

Mr. Mohsen Messaoudi is a researcher at the Université de Tunis El Manar, Faculty of Sciences of Tunis, Tunisia, specializing in molecular biology, human genetics, and population genetics. His academic work focuses on the study of genetic polymorphisms within North African populations, with particular relevance to pharmacogenomics and precision medicine. Through his research, he contributes to a deeper understanding of how genetic variability influences drug metabolism, disease risk, and therapeutic responses across diverse populations. His scholarly publications in international peer-reviewed journals reflect a commitment to rigorous scientific methodology and regional genetic research. Dr. Messaoudi actively collaborates with national and international researchers, fostering interdisciplinary exchange and strengthening research networks in biomedical sciences. The societal relevance of his work lies in its potential application to personalized healthcare strategies, improved clinical decision-making, and the development of population-specific medical guidelines, thereby supporting advances in public health and biomedical innovation in the region.

Citation Metrics (Scopus)

4
3
2
1
0

Citations

4

Documents

2

h-index

2

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications


CYP2C Gene Polymorphisms in North African Populations


– Molecular Biology Reports, 51(1), 1145 (2024)

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by Global Scholar Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Manar El-Morsy | Biochemistry, Genetics and Molecular Biology | Young Researcher Award

Published on by Global Scholar Awards

Dr . Manar El-Morsy | Biochemistry, Genetics and Molecular Biology | Young Researcher Award

Junior research at Faculty of Nanotechnology, Cairo University , Egypt

Manar Taher El-Morsy is a highly promising candidate for the Young Researcher Award, demonstrating strong academic and research capabilities in biotechnology and nanotechnology. Her innovative work on pH-sensitive nano-niosomes and grafted chitosan nanoparticles for targeted breast cancer therapy highlights her contribution to cutting-edge cancer treatment. With publications in Q1 journals, active participation in national conferences, and awards in scientific competitions, she has established herself as a driven and impactful researcher. Manar also engages in science communication as a medical writer and mentors students in research methodologies, showcasing leadership and dedication to scientific development. Her interdisciplinary projects span medical, environmental, and agricultural biotechnology, reflecting versatility and a commitment to sustainable solutions. While she would benefit from greater international exposure and advancing her English proficiency, her strong technical skills, research impact, and proactive engagement make her a highly suitable candidate for the award, with significant potential for future contributions to global science.

Professional Profile 

Education🎓

Manar Taher El-Morsy holds a Bachelor of Science degree in Biotechnology and Molecular Biology from the Faculty of Science, Cairo University, where she graduated with a “Very Good” academic standing. She is currently pursuing a Master’s degree in Bio-Nanotechnology at the Faculty of Nanotechnology, Cairo University, demonstrating her continued commitment to advanced scientific research and specialization. Throughout her academic journey, she has actively participated in scientific projects, receiving multiple certificates of completion from institutions such as Nile University and MSA University. Her education has been enriched by practical training in molecular biology techniques, nanomaterial synthesis, and bioinformatics, which she received from various esteemed institutions, including the Children’s Cancer Hospital Egypt (57357) and the Faculty of Science, Cairo University. Additionally, she has complemented her academic education with soft skills and analytical reasoning courses, enhancing her communication, critical thinking, and problem-solving abilities. Her academic background provides a solid foundation for her research and scientific contributions.

Professional Experience📝

Manar Taher El-Morsy has built a strong professional foundation in biotechnology and nanotechnology through diverse roles in research, instruction, and science communication. Since 2021, she has worked as a freelance researcher, focusing on drug delivery systems, cancer therapy, and sustainable biotechnological applications. Her role as a medical writer since 2022 has involved authoring and co-authoring review articles in Q1 journals, demonstrating her ability to translate complex scientific content for academic audiences. She has also served as a research instructor, mentoring students in research methodologies and project execution. Currently, she works as a research assistant at the Animal Health Research Institute, contributing to applied scientific studies. Her professional experience is further supported by participation in national and international conferences, workshops, and competitions, showcasing her skills in presentation, collaboration, and innovation. Through these roles, she has demonstrated a strong commitment to advancing scientific research and sharing knowledge with both academic and public audiences.

Research Interest🔎

Manar Taher El-Morsy’s research interests lie at the intersection of biotechnology, nanotechnology, and cancer therapy, with a particular focus on developing innovative drug delivery systems. She is deeply engaged in exploring smart nanocarriers, such as pH-sensitive nano-niosomes and grafted chitosan nanoparticles, for targeted treatment of aggressive cancers like triple-negative breast cancer. Her work also extends to sustainable technologies, including microbial fuel cells for waste management and nanotechnology-based solutions in agriculture. Manar is passionate about utilizing natural extracts and biopolymers in nanomedicine to create more effective and eco-friendly therapeutic options. Additionally, she has a strong interest in bionanosensors, molecular biology techniques, and the integration of bioinformatics tools to enhance research outcomes. Her goal is to contribute to global health by advancing precision medicine and sustainable biotechnology solutions. This multidisciplinary approach reflects her commitment to solving real-world challenges through innovative and scientifically rigorous research.

Award and Honor🏆

Manar Taher El-Morsy has received several prestigious awards and honors that reflect her academic excellence, research innovation, and leadership potential. She won 1st Place in the National Biotechnology Competition “Science Operation Leaders” (SOLE) in Egypt, recognizing her outstanding scientific knowledge and problem-solving skills. She also earned 1st Place in the Giza Governorate Short Story Writing Competition, highlighting her strength in scientific and creative communication. Manar was awarded multiple certificates of completion for her scientific projects at Cairo University, MSA University, and Nile University, where her research on pH-sensitive nano-niosomes was recognized. She was also a participant in the INJAZ Al Arab Competition in Dubai, showcasing her work on entrepreneurship and innovation. In addition, she received recognition from the Armed Forces’ BIC Competition and participated in the AgriTech4Egypt Innovation Challenge Bootcamp. These accolades collectively underscore her commitment to scientific advancement, interdisciplinary collaboration, and societal impact through research and innovation.

Research Skill🔬

Manar Taher El-Morsy possesses a diverse and advanced set of research skills that support her work in biotechnology, nanotechnology, and cancer therapy. She is proficient in molecular biology techniques such as PCR, DNA/RNA extraction, and gel electrophoresis, which are fundamental to her experimental work. In nanotechnology, she excels in the synthesis and characterization of nanomaterials and polymers, skills crucial for developing innovative drug delivery systems. Manar is also skilled in scientific writing and experimental design, allowing her to effectively communicate complex research findings in high-impact journals. Her bioinformatics training enhances her ability to analyze biological data, supporting data-driven decision-making in research. She has demonstrated competence in designing and implementing independent and collaborative projects, mentoring students, and presenting at national conferences. Her ability to integrate technical expertise with analytical thinking, problem-solving, and strong communication makes her a capable and innovative researcher dedicated to advancing science and addressing real-world challenges.

Conclusion💡

Manar Taher El-Morsy demonstrates exceptional promise as a young scientist. Her research is innovative, multidisciplinary, and impactful, particularly in areas such as cancer nanomedicine and sustainable biotechnology. She is actively engaged in scientific dissemination, mentoring, and leadership activities.

Given her trajectory, strong academic and publication record, and commitment to advancing science in Egypt and beyond, she is a compelling candidate for the Young Researcher Award, with only minor areas to refine for even broader recognition.

Publications Top Noted✍

  • Title: Metal–organic frameworks in drug delivery: engineering versatile platforms for therapeutic applications
    Authors: DSR Khafaga, MT El-Morsy, H Faried, AH Diab, S Shehab, AM Saleh, …
    Year: 2024
    Citations: 25

  • Title: Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics
    Authors: G Muteeb, DSR Khafaga, MT El-Morsy, M Farhan, M Aatif, M Hosney
    Year: 2024
    Citations: 4

  • Title: Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems
    Authors: G Muteeb, MT El-Morsy, MA Abo-Taleb, SK Mohamed, DSR Khafaga
    Year: 2024
    Citations: Not listed (assumed 0 or pending indexing)

 

 

 

Gareth Baynam | Genetics | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Gareth Baynam | Genetics | Best Researcher Award

Medical Director  at The Rare Care Centre, Perth Children’s Hospital, Australia

Clinical Professor Gareth Baynam is a globally recognized leader in rare diseases, precision public health, and equitable healthcare innovation. With over two decades of experience as a clinical geneticist and translational scientist, he holds numerous influential roles across academia, healthcare policy, and genomics research, including Director of the Undiagnosed Diseases Network International and Medical Director of the Rare Care Centre in Western Australia. His work focuses on advancing health equity, particularly for children, Indigenous populations, and those with rare diseases. Gareth has pioneered several international collaborations and state-wide initiatives, transforming research into sustainable clinical applications. His influential publications and numerous accolades, including the Western Australia Minister for Health’s Award and recognition from the Genetic and Rare Diseases Network, underscore his profound impact on healthcare systems and patient communities. His innovative, inclusive, and patient-centered approach makes him a strong and highly suitable candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Professor Gareth Baynam possesses an impressive and multidisciplinary educational background that underpins his impactful career in clinical genetics and public health innovation. He obtained his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Western Australia in 1997, followed by a Diploma in Child Health (DCH) in 1999. He earned his Fellowship from the Royal Australasian College of Physicians (FRACP) in 2001, specializing in Medicine. Driven by a passion for translational research, he completed a Ph.D. in Vaccine Genetics at the University of Western Australia in 2008, further strengthening his foundation in genomic science. In 2020, he also became an Associate Fellow of the Australasian Institute of Digital Health (A/FAIDH), reflecting his commitment to health informatics and digital health transformation. His comprehensive education equips him with the clinical, scientific, and technological expertise necessary to lead innovative healthcare initiatives and influence global health policies, particularly in rare disease research and precision medicine.

Professional Experience📝

Professor Gareth Baynam has a distinguished professional career that spans clinical practice, academic leadership, health policy, and global research collaboration. Since 2008, he has served as a Clinical Geneticist at Genetic Services of Western Australia, where he provides expert care and contributes to advancing genetic medicine. He held the position of Raine Clinician Research Fellow from 2014 to 2019, a prestigious role that allowed him to bridge clinical service with impactful research. He has served as a Clinical Associate Professor and later Clinical Professor at the University of Western Australia, and also holds academic appointments at Curtin University, the University of Notre Dame, and serves on multiple national and international advisory boards. As Medical Director of the Rare Care Centre and Director of the Undiagnosed Diseases Network International, he leads innovative initiatives in rare disease diagnosis and care. His professional journey is marked by a deep commitment to equitable healthcare and translational genomics.

Research Interest🔎

Professor Gareth Baynam’s research interests lie at the intersection of clinical genetics, precision public health, and equitable healthcare delivery. He is particularly passionate about improving outcomes for individuals with rare diseases, birth defects, and cerebral palsy, with a strong focus on Indigenous and underserved communities. His work emphasizes the use of innovative technologies—ranging from ancient knowledge systems to modern genomics and digital health—to develop sustainable, patient-centered healthcare solutions. He is a pioneer in translational science, transforming cutting-edge research into real-world clinical applications through deep community engagement and multi-sector partnerships. Professor Baynam also plays a critical role in shaping health policy and genomic strategies at national and global levels. His efforts support the integration of precision medicine into primary care systems and promote health equity through public-private partnerships. Ultimately, his research is driven by a commitment to ensuring that scientific advances reach those most in need, creating a global impact in rare disease care.

Award and Honor🏆

Professor Gareth Baynam has received numerous prestigious awards and honors in recognition of his exceptional contributions to healthcare, research, and innovation. In 2019, he was awarded the Western Australia Minister for Health’s Award—the highest accolade in the WA Health System—for his significant and sustainable impact on population-scale health innovations, particularly benefiting children, youth with rare diseases, and Aboriginal communities. In 2018, he was bestowed with the first Honorary Lifetime Membership of the Genetic and Rare Diseases Network WA (GaRDN), honoring his tireless dedication and collaborative efforts to improve the lives of those affected by genetic and rare diseases. He was also a finalist in the 2019 Premier’s Science Awards, reflecting his prominence in scientific advancement. More recently, in 2024, he was named a finalist for both the Channel 7 Child Health Hero and the NMHS NAIDOC Award, further highlighting his continued excellence in child health advocacy and Indigenous health initiatives.

Research Skill🔬

Professor Gareth Baynam possesses a comprehensive and impactful set of research skills that span clinical genetics, public health, policy development, and translational science. He excels in designing and implementing research frameworks that bridge the gap between cutting-edge science and real-world healthcare delivery, particularly in the context of rare diseases and underserved populations. His skills include leading multi-disciplinary, cross-sectoral collaborations and translating complex genomic research into accessible clinical applications. He is adept in data-driven innovation, combining modern informatics with traditional and community-based knowledge to address health disparities. Professor Baynam demonstrates exceptional ability in stakeholder engagement, having successfully coordinated national and international initiatives involving governments, NGOs, industry partners, and Indigenous communities. He also contributes to health system reforms through policy advising, guideline development, and capacity-building. His research leadership has not only advanced scientific understanding but also ensured that innovations lead to tangible, sustainable improvements in patient care and health equity globally.

Conclusion💡

Professor Gareth Baynam stands out as an exemplary candidate for the Best Researcher Award due to his:

  • Leadership in global health and rare disease research.

  • Multidisciplinary and international contributions.

  • Commitment to equitable, inclusive, and translational science.

  • Recognized excellence through prestigious awards and global collaborations.

He not only meets but exceeds the typical criteria expected for this award. With minor enhancements in showcasing commercialization potential and international collaborations (esp. with Singapore), his profile could serve as a benchmark for impactful, socially conscious scientific leadership.

Publications Top Noted✍️

  • Title: The human phenotype ontology in 2021
    Authors: S Köhler, M Gargano, N Matentzoglu, LC Carmody, D Lewis-Smith, et al.
    Year: 2021
    Citations: 901

  • Title: Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
    Authors: S Köhler, L Carmody, N Vasilevsky, JOB Jacobsen, D Danis, JP Gourdine, et al.
    Year: 2019
    Citations: 743

  • Title: The human phenotype ontology in 2017
    Authors: S Köhler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Aymé, et al.
    Year: 2017
    Citations: 653

  • Title: How many rare diseases are there?
    Authors: M Haendel, N Vasilevsky, D Unni, C Bologa, N Harris, H Rehm, et al.
    Year: 2020
    Citations: 464

  • Title: International cooperation to enable the diagnosis of all rare genetic diseases
    Authors: KM Boycott, A Rath, JX Chong, T Hartley, FS Alkuraya, G Baynam, et al.
    Year: 2017
    Citations: 447

  • Title: The human phenotype ontology in 2017
    Authors: S Kohler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Ayme, et al.
    Year: 2017
    Citations: 383

  • Title: Mutations in a TGF-β Ligand, TGFB3, Cause Syndromic Aortic Aneurysms and Dissections
    Authors: AM Bertoli-Avella, E Gillis, H Morisaki, JMA Verhagen, BM De Graaf, et al.
    Year: 2015
    Citations: 341

  • Title: Modeling 3D facial shape from DNA
    Authors: P Claes, DK Liberton, K Daniels, KM Rosana, EE Quillen, LN Pearson, et al.
    Year: 2014
    Citations: 335

  • Title: X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes
    Authors: H Hu, SA Haas, J Chelly, H Van Esch, M Raynaud, APM de Brouwer, et al.
    Year: 2016
    Citations: 330

  • Title: Rights, interests and expectations: Indigenous perspectives on unrestricted access to genomic data
    Authors: M Hudson, NA Garrison, R Sterling, NR Caron, K Fox, J Yracheta, et al.
    Year: 2020
    Citations: 255

  • Title: Future of rare diseases research 2017–2027: an IRDiRC perspective
    Authors: CP Austin, CM Cutillo, LPL Lau, AH Jonker, A Rath, D Julkowska, et al.
    Year: 2017
    Citations: 255

  • Title: The human phenotype ontology: semantic unification of common and rare disease
    Authors: T Groza, S Köhler, D Moldenhauer, N Vasilevsky, G Baynam, T Zemojtel, et al.
    Year: 2015
    Citations: 240

  • Title: Extending the phenotypes associated with DICER1 mutations
    Authors: WD Foulkes, A Bahubeshi, N Hamel, B Pasini, S Asioli, G Baynam, et al.
    Year: 2011
    Citations: 215

  • Title: Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X‐Linked Kabuki Syndrome Subtype 2
    Authors: N Bögershausen, V Gatinois, V Riehmer, H Kayserili, J Becker, et al.
    Year: 2016
    Citations: 197

Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

College teachers at Guangdong Pharmaceutical University, China

Professor Ze-Min Yang is a distinguished researcher specializing in metabolic disease pathogenesis and pharmacological research integrating Traditional Chinese Medicine (TCM) with Western medicine. With over 40 academic publications, including 13 SCI-indexed papers, and three invention patents, he has made significant contributions to biomedical research. He has led multiple prestigious projects, including National Natural Science Foundation grants and provincial research collaborations, demonstrating strong leadership and innovation. Serving as Deputy Director at Guangdong Pharmaceutical University, he plays a key role in academic mentorship and scientific evaluation at the provincial level. His accolades, such as “Outstanding Science and Technology Worker” and “Outstanding Teacher,” further highlight his excellence. While his research output is impressive, enhancing international collaborations, increasing citation impact, and expanding interdisciplinary applications could further strengthen his global recognition. Overall, his achievements and leadership make him a strong candidate for the Best Researcher Award, recognizing his impactful contributions to science and medicine.

Professional Profile 

Education

Professor Ze-Min Yang has a strong academic foundation spanning multiple disciplines. He earned his Ph.D. in 2012 from the Institute of Spleen and Stomach Research at Guangzhou University of Traditional Chinese Medicine, specializing in integrated traditional Chinese and Western medicine clinical practice. Prior to this, he obtained a Master’s degree in Hydrobiology from the Hydrobiology Research Center of Jinan University in 2005, demonstrating his expertise in biological sciences. His academic journey began with a Bachelor’s degree in Freshwater Fisheries from the Department of Fisheries at Southwest Agricultural University in 2002. This diverse educational background has provided him with a unique interdisciplinary perspective, integrating biomedical sciences, traditional medicine, and hydrobiology. His advanced training and research experience have contributed to his expertise in metabolic disease pathogenesis and pharmacological research, reinforcing his position as a leading academic in the field of biomedical and pharmaceutical sciences.

Professional Experience

Professor Ze-Min Yang has an extensive professional background in biomedical and pharmaceutical sciences. He currently serves as a faculty member in the Department of Biochemistry and Molecular Biology at the School of Basic Medical Sciences, Guangdong Pharmaceutical University. Additionally, he holds the position of Deputy Director of the Experimental Teaching Center, where he plays a key role in advancing scientific research and education. His expertise is recognized at the provincial level, as he actively contributes as an expert in science and technology project evaluation and acceptance for both Guangdong Province and Guangzhou City. Throughout his career, he has led multiple prestigious research projects, including those funded by the National Natural Science Foundation and Guangdong Provincial Science and Technology Department. His leadership in academic research, combined with his contributions to scientific evaluation and mentorship, underscores his dedication to advancing biomedical sciences and fostering innovation in traditional Chinese and Western medicine integration.

Research Interest

Professor Ze-Min Yang’s research interests focus on the pathogenesis of metabolic diseases and the pharmacological effects of integrating Traditional Chinese Medicine (TCM) with Western medicine. His work explores innovative approaches to understanding and treating metabolic disorders through a combination of molecular biology, biochemistry, and traditional herbal medicine. He is particularly interested in identifying bioactive compounds in TCM that can be used for drug development and disease management. His interdisciplinary research extends to studying the mechanisms of metabolic regulation, inflammation, and gut microbiota interactions in disease progression. By bridging modern biomedical research with traditional healing practices, he aims to develop novel therapeutic strategies that are both scientifically validated and culturally relevant. His contributions, supported by multiple national and provincial research grants, significantly advance the integration of TCM with evidence-based medicine, enhancing its global recognition and application in modern healthcare.

Award and Honor

Professor Ze-Min Yang has received numerous awards and honors in recognition of his outstanding contributions to scientific research, education, and innovation. He has been honored with titles such as “Outstanding Science and Technology Worker,” “Advanced Teaching Worker,” and “Outstanding Teacher” by Guangdong Pharmaceutical University, reflecting his excellence in both research and academia. His leadership in biomedical sciences and commitment to integrating Traditional Chinese Medicine with Western medicine have earned him prestigious recognition at institutional and provincial levels. Additionally, his contributions as an expert in science and technology project evaluation for Guangdong Province and Guangzhou City highlight his influence in shaping research policies and advancements. With multiple funded projects, over 40 academic publications, and three invention patents, his work has significantly impacted the field of metabolic disease research. These accolades reinforce his reputation as a distinguished scientist and educator, making him a strong candidate for prestigious research awards.

Research Skill

Professor Ze-Min Yang possesses a diverse and advanced set of research skills, particularly in the fields of biochemistry, molecular biology, and pharmacology. His expertise lies in investigating the pathogenesis of metabolic diseases and the therapeutic potential of Traditional Chinese Medicine (TCM) integrated with Western medicine. He has extensive experience in experimental design, data analysis, and clinical applications, allowing him to bridge theoretical research with practical medical solutions. His work involves drug discovery, biomarker identification, and molecular mechanism studies, utilizing cutting-edge laboratory techniques such as cell culture, gene expression analysis, and bioinformatics. Additionally, his ability to lead multi-disciplinary research projects, secure national and provincial funding, and collaborate with experts in biomedical sciences demonstrates his strong project management and leadership skills. His contributions, including over 40 academic publications and three patents, highlight his ability to drive innovative research that advances both scientific knowledge and clinical applications.

Conclusion

Professor Ze-Min Yang is a strong candidate for the Best Researcher Award due to his extensive research in metabolic diseases, leadership in TCM and Western medicine integration, multiple prestigious grants, and significant academic contributions. To further enhance his profile, international collaborations, higher-impact publications, and broader interdisciplinary work would strengthen his candidacy.

Publications Top Noted

  • Title: “Identification of microRNA and analysis of target genes in Panax ginseng”

    Authors: Yingfang Wang, Yanlin Chen, Mengyuan Peng, Yongqin Yin, Yu Zeng

    Year: 2023

    Citations: 8

    Source: Chinese Herbal Medicines

  • Title: “Astragalus Polysaccharides Alleviate Type 2 Diabetic Rats by Reversing the Expressions of Sweet Taste Receptors and Genes Related to Glycolipid Metabolism in Liver”

    Authors: Mengjuan Luo, Ying Wang, Siyu Chen, Zemin Yang

    Year: 2022

    Citations: 14

    Source: Frontiers in Pharmacology